Even after reaching the weight goal established with a provider, discontinuing GLP-1s doesn't necessarily mark the end of the treatment journey
Adverse events, notably pedal edema and dizziness, were more common in the 5mg group (P = .024), while heart rate and both systolic and diastolic blood pressure remained similar between groups
Consequently, gaining insight into how key brain metabolites, such as GSH, influence behaviors and how nutrition can enhance these processes may offer a novel approach to developing effective dietary supplementation strategies to support and optimize cognitive and behavioral outcomes
Wu, Cengiz, Lawley, Obesity 2025: case series and pharmacokinetic model suggesting that reduced-frequency dosing (biweekly instead of weekly) may preserve a substantial fraction of weight-loss efficacy for maintenance
However, Juan P
The data in Table 2 reflect the exposure of 2713 adults with type 2 diabetes to TRESIBA with a mean exposure duration to TRESIBA of 36 weeks in six open-label trials